Everyday drug diversions: A qualitative study of the illicit exchange and non-medical use of prescription stimulants on a university campus

Social Science and Medicine

Volumn 131, Issue , 2015, Pages 297-304

  Vrecko, Scott ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Adderall; Drug diversion; Enhancement; Non medical drug use; Pharmaceuticalization; Pharmaceuticals; Prescription medication; United States

Indexed keywords

AMPHETAMINE DERIVATIVE; AMPHETAMINE PLUS DEXAMPHETAMINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; PRESCRIPTION DRUG;

ADOLESCENT; DECEPTION; DRUG MISUSE; DRUG TRAFFIC; FEMALE; HUMAN; LEGISLATION AND JURISPRUDENCE; MALE; PRESCRIPTION DRUG DIVERSION; PSYCHOLOGIC TEST; PSYCHOLOGY; QUALITATIVE RESEARCH; STATISTICS AND NUMERICAL DATA; STUDENT; SUBSTANCE-RELATED DISORDERS; SUPPLY AND DISTRIBUTION; YOUNG ADULT;

ADOLESCENT; AMPHETAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; DECEPTION; DRUG TRAFFICKING; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; METHYLPHENIDATE; PRESCRIPTION DRUG DIVERSION; PRESCRIPTION DRUG OVERUSE; PRESCRIPTION DRUGS; QUALITATIVE RESEARCH; STUDENTS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84925445755     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2014.10.016     Document Type: Article

References (48)

1. Arria A.M. Nonmedical use of prescription stimulants and analgesics: associations with social and academic behaviors among college students. J.Drug Issues 2008, 28:156.
2. Bazeley P. Qualitative Data Analysis with NVivo 2007, Sage Publications Ltd.
3. Bell S., Partridge B., Lucke J., Hall W. Australian university students' attitudes towards the acceptability and regulation of pharmaceuticals to improve academic performance. Neuroethics 2013, 6:197-205.
4. Bell S.E., Figert A.E. Medicalization and pharmaceuticalization at the intersections: looking backward, sideways and forward. Soc. Sci. Med. 2012, 75:775-783.
5. Bond J. Stages in cognitive impairment: boundary issues and the biomedicalisation of later life. Gerontologist 2009, 49. 87-87.
6. Charmaz K. Constructing Grounded Theory: A Practical Guide through Qualitative Analysis 2006, Sage Publications Ltd.
7. Cohen D. Critiques of the 'ADHD'enterprise. Critical New Perspectives on ADHD 2006, 12-33. Routledge, New York, NY. G. Lloyd, J. Stead, D. Cohen (Eds.).
8. Conrad P., Leiter V. Medicalization, markets and consumers. J.Health Soc. Behav. 2004, 158-176.
9. Conrad P., Potter D. From hyperactive children to ADHD adults: observations on the expansion of medical categories. Soc. Probl. 2000, 559-582.
10. Coveney C., Gabe J., Williams S. The sociology of cognitive enhancement: medicalisation and beyond. Health Sociol. Rev. 2011, 20:381-393.
11. Dumit J. Drugs for Life: How Pharmaceutical Companies Define Our Health 2012, Duke University Press, Durhma, NC.
12. Elnicki D.M. Cognitive enhancement drug use among medical students and concerns about medical student well-being. J.General Intern. Med. 2013, 28:984-985.
13. Farah M.J., Illes J., Cook-Deegan R., Gardner H., Kandel E., King P., et al. Neurocognitive enhancement: what can we do and what should we do?. Nat. Rev. Neurosci. 2004, 5:421-425.
14. Fischer B., Bibby M., Bouchard M. The global diversion of pharmaceutical drugsnon-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures. Addiction 2010, 105:2062-2070.
15. Fox N.J., Ward K.J., O'Rourke A.J. The 'expert patient': empowerment or medical dominance? The case of weight loss, pharmaceutical drugs and the Internet. Soc. Sci. Med. 2005, 60:1299-1309.
16. Fraser S., Moore D. The Drug Effect: Health, Crime and Society 2011, Cambridge University Press, Cambridge.
17. Greely H., Sahakian B., Harris J., Kessler R.C., Gazzaniga M., Campbell P., et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 2008, 456:702-705.
18. Hall K.M., Irwin M.M., Bowman K.A., Frankenberger W., Jewett D.C. Illicit use of prescribed stimulant medication among college students. J.Am. Coll. Health 2005, 53:167-174.
19. Hotze T.D., Shah K., Anderson E.E., Wynia M.K. "Doctor, would you prescribe a pill to help me. . .?" A national survey of physicians on using medicine for human enhancement. Am. J. Bioeth. 2011, 11:3-13.
20. Jones K. In whose interest? Relationships between health consumer groups and the pharmaceutical industry in the UK. Sociol. Health Illn. 2008, 30:929-943.
21. Kramer P.D. Listening to Prozac 1992, Viking, New York, N.Y.
22. Loe M. The prescription of a new generation. Contexts 2008, 7:46-49.
23. Loe M., Cuttino L. Grappling with the medicated self: the case of ADHD college students. Symb. Interact. 2008, 31:303-323.
24. Lovell A.M. Addiction markets: the case of high-dose buprenorphine in France. Global Pharmaceuticals: Ethics, Markets, Practices 2006, 136-170. Duke University Press. A. Petryna, A. Lakoff, A. Kleinman (Eds.).
25. Lucke J.C. Empirical research on attitudes toward cognitive enhancement is essential to inform policy and practice guidelines. AJOB Prim. Res. 2012, 3:58-60.
26. Maher B. Poll results: look who's doping. Nature 2008, 452:674-675.
27. McCabe S.E., Knight J.R., Teter C.J., Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction 2005, 100:96-106.
28. McCabe S.E., West B.T., Teter C.J., Boyd C.J. Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: connecting the dots. Addict. Behav. 2014, 39:1176-1182.
29. Moreira T., May C., Bond J. Regulatory objectivity in action: mild cognitive impairment and the collective production of uncertainty. Soc. Stud. Sci. 2009, 39:665-690.
30. Parens E. Enhancing Human Traits : Ethical and Social Implications 1998, Georgetown University Press, Washington, D.C.
31. Partridge B., Bell S., Lucke J., Hall W. Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety. Drug alcohol Rev. 2013, 32:295-302.
32. Petryna A. When Experiments Travel: Clinical Trials and the Global Search for Human Subjects 2009, Princeton University Press, Princeton.
33. Pilkinton M., Cannatella A. Nonmedical use of prescription stimulants: age, race, gender, and educational attainment patterns. J.Hum. Behav. Soc. Environ. 2012, 22:409-420.
34. Pollock A. Medicating Race: Heart Disease and Durable Preoccupations with Difference 2012, Duke University Press Books.
35. Poulin C. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Addiction 2007, 102:740-751.
36. Quintero G., Nichter M. Generation RX: anthropological research on pharmaceutical enhancement, lifestyle regulation, self-medication and recreational drug use. ACompanion to Medical Anthropology 2011, 339-355. Wiley. M. Singer, P.I. Erickson (Eds.).
37. Quintero G., Peterson J., Young B. An exploratory study of socio-cultural factors contributing to prescription drug misuse among college students. J.Drug Issues 2006, 36:903-931.
38. Rudski J.M. Acomparison of attitudes toward pharmacological treatment versus enhancement under competitive and noncompetitive conditions. AJOB Empir. Bioeth. 2014, 5:80-90.
39. Singh I., Kelleher K.J. Neuroenhancement in young people: proposal for research, policy, and clinical management. AJOB Neurosci. 2010, 1:3-16.
40. Singh I., Kendall T., Taylor C., Mears A., Hollis C., Batty M., et al. Young people's experience of ADHD and stimulant medication: a qualitative study for the NICE guideline. Child Adolesc. Ment. health 2010, 15:186-192.
41. Stevenson F.A., Leontowitsch M., Duggan C. Over-the-counter medicines: professional expertise and consumer discourses. Sociol. Health Illn. 2008, 30:913-928.
42. Teter C.J., McCabe S.E., LaGrange K., Cranford J.A., Boyd C.J. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy 2006, 26:1501-1510.
43. Varga M.D. Adderall abuse on college campuses: a comprehensive literature review. J.Evidence-Based Soc. Work 2012, 9:293-313.
44. Vrecko S. Just how cognitive is "cognitive enhancement"? On the significance of emotions in university students' experiences with study drugs. AJOB Neurosci. 2013, 4:4-12.
45. Wahlberg A., McGoey L. An elusive evidence base: the construction and governance of randomized controlled trials. Biosocieties 2007, 2:1-10.
46. Whitehouse P., Gaines A.D., Lindstrom H., Graham J.E. Anthropological contributions to the understanding of age-related cognitive impairment. Lancet Neurol. 2005, 4:320-326.
47. Wilens T.E., Adler L.A., Adams J., Sgambati S., Rotrosen J., Sawtelle R., et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J.Am. Acad. Child Adolesc. Psychiatry 2008, 47:21-31.
48. Williams S.J., Martin P., Gabe J. The pharmaceuticalisation of society? A framework for analysis. Sociol. health & Illn. 2011, 33:710-725.